Indusind Bank (IIB) Earnings: 2Q Net Income Falls Short of Estimates Amid Rising Provisions and Operating Profit Decline

Indusind Bank on Smartkarma

Analyst coverage of Indusind Bank on Smartkarma, a platform for independent investment research, includes insights from Victor Galliano. In his report titled “Indian Banks Screener FYE24, Part 2: Bandhan and UBI added to the buy list,” Galliano expresses a bullish sentiment. He highlights the addition of value plays Bandhan and UBI to the buy list, alongside other banks like HDFC Bank and Baroda. Galliano’s report also notes a shift in stance, turning neutral from negative on SBI. He identifies Bandhan as the core Indian bank pick and mentions that UBI stands to benefit from improving return trends.

A look at Indusind Bank Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Indusind Bank is positioned well for the long term. With high scores in areas like Dividend and Value, the bank demonstrates strong fundamentals and a commitment to rewarding shareholders. Its solid scores in Growth and Resilience indicate a balanced approach to expansion and risk management. However, the lower Momentum score suggests a slower pace in terms of market performance and investor interest.

Indusind Bank Limited, a Mumbai-based new generation bank established in 1994, offers a diverse range of banking and financial services. With branches across India and presence in international hubs like Dubai and London, the bank caters to various segments including wholesale banking, investment banking, and commercial lending. The Smart Scores highlight the bank’s strengths in areas like dividend payouts and underlying value, positioning it well for future growth and stability.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma